Follow
Zahra Najafi
Zahra Najafi
Department of Medicinal Chemistry, School of Pharmacy, Hamadan University of Medical Sciences
Verified email at umsha.ac.ir - Homepage
Title
Cited by
Cited by
Year
Novel tacrine-coumarin hybrids linked to 1, 2, 3-triazole as anti-Alzheimer’s compounds: In vitro and in vivo biological evaluation and docking study
Z Najafi, M Mahdavi, M Saeedi, E Karimpour-Razkenari, N Edraki, ...
Bioorganic chemistry 83, 303-316, 2019
1172019
Novel tacrine-1, 2, 3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors
Z Najafi, M Mahdavi, M Saeedi, E Karimpour-Razkenari, R Asatouri, ...
European journal of medicinal chemistry 125, 1200-1212, 2017
1062017
Design and synthesis of novel anti-Alzheimer’s agents: Acridine-chromenone and quinoline-chromenone hybrids
Z Najafi, M Saeedi, M Mahdavi, R Sabourian, M Khanavi, MB Tehrani, ...
Bioorganic chemistry 67, 84-94, 2016
702016
Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer’s …
G Ghotbi, M Mahdavi, Z Najafi, FH Moghadam, M Hamzeh-Mivehroud, ...
Bioorganic Chemistry 103, 104186, 2020
492020
1, 2, 3-Triazole-Isoxazole based acetylcholinesterase inhibitors: Synthesis, biological evaluation and docking study
Z Najafi, M Mahdavi, M Saeedi, R Sabourian, M Khanavi, M Safavi, ...
Letters in Drug Design & Discovery 14 (1), 58-65, 2017
232017
Synthesis of pyridinium-based salts: Catalytic application at the synthesis of six membered O-heterocycles
S Babaee, MA Zolfigol, M Zarei, M Abbasi, Z Najafi
Molecular Catalysis 475, 110403, 2019
222019
Novel cinnamic acid–tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study
S Ghafary, Z Najafi, M Mohammadi‐Khanaposhtani, H Nadri, N Edraki, ...
Archiv der Pharmazie 351 (10), 1800115, 2018
182018
Novel Tacrine‐Based Pyrano[3’,4’:5,6]pyrano[2,3‐b]quinolinones: Synthesis and Cholinesterase Inhibitory Activity
R Hariri, Z Afshar, M Mahdavi, M Safavi, M Saeedi, Z Najafi, R Sabourian, ...
Archiv der Pharmazie 349 (12), 915-924, 2016
182016
Design, synthesis, and molecular docking of some novel tacrine based cyclopentapyranopyridin‐and tetrahydropyranoquinolin‐kojic acid derivatives as anti‐acetylcholinesterase agents
S Babaee, G Chehardoli, T Akbarzadeh, MA Zolfigol, M Mahdavi, ...
Chemistry & Biodiversity, 2021
172021
Synthesis and In Vitro Cytotoxic Activity of Novel Triazole‐Isoxazole Derivatives
Z Najafi, M Mahdavi, M Safavi, M Saeedi, H Alinezhad, M Pordeli, ...
Journal of Heterocyclic Chemistry 52 (6), 1743-1747, 2015
172015
Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer’s disease: Quinolotacrine hybrids
M Sadafi Kohnehshahri, G Chehardoli, M Bahiraei, T Akbarzadeh, ...
Molecular Diversity, 1-15, 2022
162022
Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase
S Ghafary, R Ghobadian, M Mahdavi, H Nadri, A Moradi, T Akbarzadeh, ...
DARU Journal of Pharmaceutical Sciences 28, 463-477, 2020
162020
New benzyl pyridinium derivatives bearing 2, 4-dioxochroman moiety as potent agents for treatment of Alzheimer’s disease: Design, synthesis, biological evaluation, and docking …
M Mollazadeh, M Mohammadi-Khanaposhtani, A Zonouzi, H Nadri, ...
Bioorganic Chemistry 87, 506-515, 2019
152019
Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer’s disease
A Rastegari, M Safavi, F Vafadarnejad, Z Najafi, R Hariri, SNA Bukhari, ...
Molecular Diversity, 1-20, 2022
142022
Investigation of polysaccharide extracts from Iranian and French strains of Agaricus subrufescens against enzymes involved in Alzheimer’s disease.
S Rahmani-Nezhad, S Dianat, V Mahdizadeh, Z Fooladi, R Hariri, Z Najafi, ...
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 18 (6), 2019
132019
Design, synthesis, in vitro, and in silico studies of novel benzylidene 6-methoxy-1-tetralone linked to benzyloxy and benzyl-1, 2, 3-triazole rings as potential tyrosinase …
Z Najafi, A Ebadi, G Chehardoli, M Ziaei, T Akbarzadeh, M Saeedi, ...
Journal of Molecular Structure 1271, 134018, 2023
102023
Synthesis of Novel Pyrimido[4,5-b] Quinolines Containing Benzyloxy and 1,2,3-Triazole Moieties by DABCO as a Basic Catalyst
S Esmaili, AR Moosavi-Zare, A Khazaei, Z Najafi
ACS omega 7 (49), 45314-45324, 2022
102022
Ultrasound-assisted synthesis of kojic acid-1,2,3-triazole based dihydropyrano[3,2-b]pyran derivatives using Fe3O4@CQD@CuI as a novel nanomagnetic catalyst
Z Najafi, S Esmaili, B Khaleseh, S Babaee, M Khoshneviszadeh, ...
Scientific Reports 12 (1), 19917, 2022
92022
Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method
A Jalalvand, SB Khatouni, ZB Najafi, F Fatahinia, N Ismailzadeh, ...
Journal of Basic and Clinical Physiology and Pharmacology 33 (1), 85-95, 2022
82022
Curcumin-Derived Heterocycles as Anticancer Agents. A Systematic Review.
A Bahmani, Z Najafi, G Chehardoli
Organic Preparations and Procedures International 54 (6), 493-510, 2022
72022
The system can't perform the operation now. Try again later.
Articles 1–20